Promega Corporation

Activities: Manufacturing Research & Development Analysis

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Researchers improve performance of targeted protein degradation

Targeted protein degradation involves co-opting a cell’s natural disposal systems to remove disease causing proteins
Ingredients

Promega launches XpressAmp Direct Amplification reagents

The reagents are designed to allow COVID-19 testing labs to skip the RNA extraction process
Media

Protein purification and isolation market worth US$6370m by 2020

The market is growing due to increased R&D, as well as demand for ligand ID and rapid purification kits
Regulatory

Promega and BASF develop alternative method for detecting allergenic substances

Using a newly developed cell line
Manufacturing

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
Manufacturing

Promega builds plant to produce regulated products

Including sample preparation systems and reagents
Subscribe now